Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 31,372 | 27,406 | 27,059 | 26,259 | 24,802 |
| Operating Income | -31,372 | -27,406 | -27,059 | -26,259 | -24,802 |
| Other Income | 635 | 337 | 157 | 100 | 100 |
| Pre-tax Income | -30,737 | -27,069 | -26,902 | -26,159 | -24,702 |
| Net Income Continuous | -30,737 | -27,069 | -26,902 | -26,159 | -24,702 |
| Net Income | $-30,737 | $-27,069 | $-26,902 | $-26,159 | $-24,702 |
| EPS Basic Total Ops | -0.70 | -0.62 | -0.61 | -0.60 | -0.57 |
| EPS Basic Continuous Ops | -0.70 | -0.62 | -0.61 | -0.60 | -0.57 |
| EPS Diluted Total Ops | -0.70 | -0.62 | -0.61 | -0.60 | -0.57 |
| EPS Diluted Continuous Ops | -0.70 | -0.62 | -0.61 | -0.60 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -0.70 | -0.62 | -0.61 | -0.60 | N/A |
| EBITDA(a) | $-31,067 | $-26,857 | $-26,527 | $-25,706 | $-24,234 |